Since 1985, every October, people around the world pin on pink ribbons to commemorate Breast Cancer Awareness Month. With 1 in 8 women having an overall likelihood of developing breast cancer in their lifetime, nearly all of us is personally affected by the disease.
Breast cancer awareness—combined with continuing advances in screening and treatment—has led to a 58% reduction in mortality rate over the last sixty years. With over 2.3 million new cases worldwide in 2022, every life saved is a celebration, yet there is more work to be done. Much more.
Innovations in screening: The sooner, the better
Mammography, using x-rays to detect lesions before they can be palpated, is the current diagnostic method for breast cancer. Most women receive 2D digital mammography, where two x-rays are taken, one each from the top and the side. A radiologist reviews all images and is able to view and magnify any areas of concern; images are stored to compare to future mammograms.
Technology is always searching for more specific methods to identify abnormalities at the earliest possibles stages. For women with dense breast tissue or with high-risk factors, providers have several options:
- Digital Breast Tomosynthesis (DBT) or 3D mammography is becoming more available across the country. DBT allows for images to be taken from different angles, then recreated to as a 3D reproduction of a breast. Although more expensive than 2D images, it allows for more accurate views. It also means fewer “callbacks” to obtain more images.
- Contrast-Enhanced Mammography (CEM) and Contrast MRI both use
a contrast dye that is injected into the bloodstream before starting the screening. The dye allows radiologists to see any suspicious blood flow to tumors. CEM is not considered a routine screening tool but rather for evaluating dense breast tissue; screening high-risk patients; in place of a mammogram when there is noticeable lump, skin dimpling, or nipple discharge; and when patients are unable to have an MRI.
Ultrasound Elastography is based on the theory that malignant tumors are stiffer than benign ones. Using ultrasound wave scan generate waves that expose deformation or suspicious displacement.
Physical health: AI is probably already at work
If you wear a smartwatch or use a smartphone, right now AI is counting your steps, measuring your heart rate, or evaluating your movement. While you sleep, it’s checking the quality of your rest.
Wearable technology and medical devices have merged, allowing for accurate and unique data that can change your life. Here are some ways AI can boost physical wellness:
- Wearables encourage more activity by tracking distance, calories, and energy levels.
- Fitness apps analyze your workout and make adjustments based on your progress.
- Nutrition programs assess dietary habits and suggest changes to meet your weight and health goals.
- Heart monitors detect undiagnosed rhythms before a serious cardiac event occurs.
- Sensors provide continuous monitoring of blood glucose levels, avoiding dangerous high or low blood sugar emergencies.
- Apps track details about migraine headaches, such as menstrual cycles, symptoms, triggers, and barometric changes. They can predict migraine episodes and their duration.
Innovations in treatment: More specific for better outcomes
Researchers have been encouraged by breakthroughs in targeted therapies to deliver precise treatments that minimize unnecessary tissue destruction or complications. The use of AI to detect patterns and predict risk help providers maintain safe therapy margins without harming or overtreating patients. Other developments include:
- Drugs receiving FDA Fast-Track approval, such as vepdegestrant that can destroy estrogen receptors and slow progression of metastasis
- Immunotherapy trains the patient’s own immune system to identify and destroy “foreign” cancer cells.
- Improved methods to create realistic tattoos. For women who have nipple and aureola removed. Multicolored ink techniques can simulate a 3D effect to make reconstruction look and feel natural.
Breast cancer care disparities
Despite being the most common malignancy that affects every race and ethnic group, detection and treatment of breast cancer remain sadly unequal at every stage:
- Non-Hispanic White women are the most likely to be diagnosed than any other racial group.
- Black women are 42% more likely to die at every age—even among other patients with similar stages and tumor subtypes.
- Although Hispanic women have a lower incidence of breast cancer, their disease is often diagnosed at a later stage, leading to worse outcomes.
- Disparities are often affected by patients’ by socioeconomic status, access to healthcare, mistrust of the medical system, and inadequate patient-provider communication.
- Promising clinical trials are frequently limited to patients with the ability to be recruited by major pharmaceutical companies, travel to researcher trial sites with funding that will support minority and diverse patient demographics, in contrast to “mainstream” clinical trials held at major urban sites.
Living well after breast cancer diagnosis
Thankfully, breast cancer is treatable and curable. Following treatment, you can return to a routine and lifestyle that allows you, your family, and friends to look forward making memories for years to come.
- Prioritize YOU! Do all the things you would tell someone else to do. Eat healthy, well-balanced meals; get plenty of exercise and sleep; enjoy time with family and friends.
- Be patient with yourself. Breast cancer treatment is rigorous, with side effects that can be both short- and long-acting. Be familiar with your therapies and what to expect, so you know how to prepare.
- Find and use your support groups. Don’t be shy about asking for help. Spend time with the people who are important to you. Don’t feel you should be independent when your treatment is done. Continue with your breast cancer survivors’ group.
- Keep up with all appointments and learn how to detect signs of recurrence, such as a new lump.
Sources
- American Cancer Society, Hagerstown, MD. Key Statistics for Breast Cancer. 5 May 2025. Accessed online 7 September 2025.
- American Cancer Society, Hagerstown, MD. Newer and Experimental Breast Imaging Tests. 14 January 2022. Accessed online 10 September 2025.
- Barry K, Evans C, Digital Breast Tomosynthesis for Breast Cancer Screening. AFP Journal, American Academy of Family Physicians, 1 April 2021. Accessed online 10 September 2025.
- Caswell-Jin J et al. Analysis of Breast Cancer Mortality in the US –1975 to 2019. Journal of the American Medical Association (JAMA), 16 January 2024. Accessed online 7 September 2025.
- Centers for Disease Control and Prevention, Atlanta, GA. Breast Cancer Risk Factors. 30 July 2025. Accessed online 15 September 2025.
- Centers for Disease Control and Prevention, Atlanta, GA. Screening for Breast Cancer. 16 September 2025. Accessed online 7 September 2025.
- Chopra S, Khosla M, Vidya R. Innovations and Challenges in Breast Cancer Care: A Review. Medicina, 16 May 2023. Accessed online 10 September 2025.
- Doering-Domanus S. 4 things you can do to improve your quality of life after breast cancer. Interview with Daniela Stan, MD, 19 October 2022. Mayo Clinic Comprehensive Cancer Center
- Gunduru M, Grigorian C. Breast Magnetic Resonance Imaging, StatPearls, National Library of Medicine, National Center for Biotechnology. 28 August 2023. Accessed online 10 September 2025.
- Hill H, Kearns B, Pashayan N, et al. The cost-effectiveness of risk-stratified breast cancer screening in the UK. British Journal of Cancer, 17 October 2023. Accessed online 7 September 2025.
- Houser M, Barreto D, Mehta A, Brem R. Current and Future Directions of Breast MRI. Journal of Clinical Medicine, 30 November 2021. Accessed online 10 September 2025.
- Malhotra P. Mammograms: Everything You Need to Know. Breast Cancer Research Foundation, New York, NY. June 2025. Accessed online 10 September 2025.
- Mayo Clinic.Recurrent Breast Cancer, 19 April 24. Accessed online 16 September 2025.
- National Breast Cancer Foundation, Dallas, TX. Breast Cancer Stats and Facts, Last updated 22 August 2025. Accessed line 7 September 2025.
- Nicosia L, Gnocchi G, Gorini I, et al. History of Mammography: Analysis of Breast Imaging Diagnostic Achievements over the Last Century. Healthcare, 30 May 2023. Accessed online 10 September 2025.
- Nissan N, Albiztegui R, Brot H, et al. Extremely dense breasts: A comprehensive review of increased cancer risk and supplementary screening methods. European Journal of Radiology, Volume 182, January 2025. Accessed online 15 September 2025.
- O’Reilly S, Luis, IV, Adam V, et al. Advancing equitable access to innovation in breast cancer. Nature, npj Breast Cancer 11, 2025. Accessed online 10 July 2025. Accessed online. 5 September 2025.
- Puckett Y, Sule A. Disparity in Early Detection of Breast Cancer. StatPearls, National Library of Medicine, National Center for Biotechnology Information. Updated 22 June 2025.
- Susan G. Komen, What’s New in Breast Cancer, July 23, 2025. Accessed online 1 September 2025.
- Reid-De Jong V, Bruce A, Mastectecomy tattoos: An emerging alternative for reclaiming self
- Talley M, Starzyk K, et al. Mammography screening outcomes for women screened by standard versus high resolution digital breast tomosynthesis. Clinical Imaging, Volume 125, September 2025. Accessed online 10 September 2025.
- Tomlinson-Hansen S, Budh D, Sapra A. Breast Cance Screening in the Average Risk Patient, StatPearls, National Library of Medicine, National Center for Biotechnology, 3 October 2024. Accessed online 7 September 2025.
- Weaver O. What is a contrast-enhanced mammogram? Cancerwise, University of Texas, MD Anderson Center, 2 October 2024. Accessed online 10 September 2025.